Search - tctmd.com

Displaying 81 - 100 of 841

Sort: Relevancy | Date

Presentation TCT 2024

TCT 791: Do Females Have Less Effect of Mircoaxial Flow Pump in Infarct Related Cardiogenic Shock: A Secondary Analysis of the Danger Shock Trial

Presenter: Norman Mangner

October 29, 2024

Presentation TCT 2024

TCT 460: Left Atrial Venoarterial Extra-Corporeal Membrane Oxygenation (LAVA-ECMO) Compared to Combination VA-ECMO and Impella (ECPELLA) in the Management of AMI-CS

Presenter: Raef Fadel

October 28, 2024

Presentation TCT 2024

TCT 1550: Cold Extremities and Warm-Antibodies: A Case Report of Acute Cardiogenic Shock in the Setting of Myocardial Infarction and Autoimmune Hemolytic Anemia

Presenter: Monica Ferrante

October 28, 2024

Presentation TCT 2024

TCT 1363: Early Implementation of Impella CP Support in Patient With Cardiogenic Shock

Presenter: Artur Pawlik

October 28, 2024

News Conference News TCT 2024

New DanGer Shock Data: Hemodynamics, Renal Dysfunction, and Bleeding

Caitlin E. Cox

October 28, 2024

Presentation TCT 2024

TCT 1458: Calcified Left Main Bifurcation in a Patient With Acute Coronary Syndrome Complicated With Cardiogenic Shock: What Is the Optimal Approach?

Presenter: Hassan Ashraf

October 28, 2024

Presentation TCT 2024

TCT 1510: Mitral Valve Transcatheter Edge-to-Edge Repair and Multivessel Percutaneous Coronary Intervention in Cardiogenic Shock Requiring Mechanical Circulatory Support

Presenter: Joshua Zuniga

October 28, 2024

Presentation TCT 2024

How Cardiogenic Shock Working Group (CSWG) Registry Findings have Advanced Understanding of Pathophysiology, Prognosis and Therapeutics

Presenter: Navin Kapur

October 28, 2024

Presentation TCT 2024

The AHA Cardiogenic Shock Registry: Goals and Status Update

Presenter: Mariell Jessup

October 28, 2024

Presentation TCT 2024

Registries and Pragmatic Randomized Shock trials: how and why they should be used to study therapies for Cardiogenic Shock

Presenter: Mitchell Krucoff

October 28, 2024

Presentation TCT 2024

The Critical Care Cardiology Trial Network Shock Registry: How C3TN Findings Have Advanced Understanding of Pathophysiology, Prognosis and Therapeutics

Presenter: David Morrow

October 28, 2024

Presentation TCT 2024

How Far Can We Push Observational Data to Answer Clinical Questions: Statistical Considerations

Presenter: Robert Yeh

October 28, 2024

Presentation TCT 2024

TCT 579: Comparison of Outcomes of Intra-Aortic Balloon Pump Placed Through Axillary Artery vs Femoral: A Multicenter Observational Analysis From the Cardiogenic Shock Working Group (CSWG)

Presenter: Arvind Bhimaraj

October 28, 2024

Presentation TCT 2024

TCT 1258: Simultaneous Kissing Stents in Acute Left Main Coronary Artery Occlusion Complicated With Cardiogenic Shock: A Case Study

Presenter: Mustafa Turkmani

October 28, 2024

Presentation TCT 2024

Impact of Microaxial Flow Pump on Central Hemodynamics and Use of Vasoactive Drugs During Intensive Care After Infarct-Related Cardiogenic Shock: A Secondary Analysis of the DanGer Shock Trial

Presenter: Nanna Louise Junker Udesen

October 27, 2024

Presentation TCT 2024

Microaxial Flow Pump Use and Renal Outcomes in Cardiogenic Shock: An Analysis of the DanGer Shock Trial

Presenter: Jacob Moeller

October 27, 2024

Presentation TCT 2024

Impact of Bleeding Complications on Clinical Outcomes in Patients Undergoing Impella Support in Cardiogenic Shock

Presenter: Lene Holmvang

October 27, 2024

Presentation TCT 2024

TCT 457: Resource Utilization Associated With Impella Versus Extracorporeal Membrane Oxygenation in Infarct-Related Cardiogenic Shock Patients

Presenter: Margriet Bogerd

October 27, 2024

Presentation TCT 2024

TCT 456: Influence of Venoarterial Extracorporeal Membrane Oxygenation Timing on Outcome in Patients With Infarct-Related Cardiogenic Shock: A Subanalysis From the ECLS-SHOCK Trial

Presenter: Adrian Springer

October 27, 2024

Presentation TCT 2024

Cardiogenic Shock: Recognition, Management, and the Role of thee Shock Team

Presenter: Sheridan Thompson

October 27, 2024

Advertisement

TCT 791: Do Females Have Less Effect of Mircoaxial Flow Pump in Infarct Related Cardiogenic Shock: A Secondary Analysis of the Danger Shock Trial

TCT 460: Left Atrial Venoarterial Extra-Corporeal Membrane Oxygenation (LAVA-ECMO) Compared to Combination VA-ECMO and Impella (ECPELLA) in the Management of AMI-CS

TCT 1550: Cold Extremities and Warm-Antibodies: A Case Report of Acute Cardiogenic Shock in the Setting of Myocardial Infarction and Autoimmune Hemolytic Anemia

TCT 1363: Early Implementation of Impella CP Support in Patient With Cardiogenic Shock

New DanGer Shock Data: Hemodynamics, Renal Dysfunction, and Bleeding

TCT 1458: Calcified Left Main Bifurcation in a Patient With Acute Coronary Syndrome Complicated With Cardiogenic Shock: What Is the Optimal Approach?

TCT 1510: Mitral Valve Transcatheter Edge-to-Edge Repair and Multivessel Percutaneous Coronary Intervention in Cardiogenic Shock Requiring Mechanical Circulatory Support

How Cardiogenic Shock Working Group (CSWG) Registry Findings have Advanced Understanding of Pathophysiology, Prognosis and Therapeutics

The AHA Cardiogenic Shock Registry: Goals and Status Update

Registries and Pragmatic Randomized Shock trials: how and why they should be used to study therapies for Cardiogenic Shock

The Critical Care Cardiology Trial Network Shock Registry: How C3TN Findings Have Advanced Understanding of Pathophysiology, Prognosis and Therapeutics

How Far Can We Push Observational Data to Answer Clinical Questions: Statistical Considerations

TCT 579: Comparison of Outcomes of Intra-Aortic Balloon Pump Placed Through Axillary Artery vs Femoral: A Multicenter Observational Analysis From the Cardiogenic Shock Working Group (CSWG)

TCT 1258: Simultaneous Kissing Stents in Acute Left Main Coronary Artery Occlusion Complicated With Cardiogenic Shock: A Case Study

Impact of Microaxial Flow Pump on Central Hemodynamics and Use of Vasoactive Drugs During Intensive Care After Infarct-Related Cardiogenic Shock: A Secondary Analysis of the DanGer Shock Trial

Microaxial Flow Pump Use and Renal Outcomes in Cardiogenic Shock: An Analysis of the DanGer Shock Trial

Impact of Bleeding Complications on Clinical Outcomes in Patients Undergoing Impella Support in Cardiogenic Shock

TCT 457: Resource Utilization Associated With Impella Versus Extracorporeal Membrane Oxygenation in Infarct-Related Cardiogenic Shock Patients

TCT 456: Influence of Venoarterial Extracorporeal Membrane Oxygenation Timing on Outcome in Patients With Infarct-Related Cardiogenic Shock: A Subanalysis From the ECLS-SHOCK Trial

Cardiogenic Shock: Recognition, Management, and the Role of thee Shock Team

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content